Forbion closes oversubscribed Fourth Life Sciences VC Fund at EUR 360million
Posted on October 1, 2018 in Forbion, Highlights
Naarden, The Netherlands, and Munich, Germany, 1 October 2018 – Forbion, a leading European life science venture capital firm, has today announced the final close of its new flagship fund, Forbion IV. The fund closed above its original target at EUR 360 million and was significantly oversubscribed.
Please read full pressrelease here.
